Skip to main content
HR 4395 108th Congress House Crime and Law Enforcement Chemicals Commerce Drug abuse Drug industry Drug law enforcement Drug traffic Drugs Health Methamphetamine Packaging

Ephedrine Alkaloids Regulation Act of 2004

Introduced: May 19, 2004 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 28, 2004
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jun 7, 2004
Referred to the Subcommittee on Health.
May 19, 2004
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2004
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Ephedrine Alkaloids Regulation Act of 2004 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of the Controlled Substances Act (CSA). Excepts pseudoephedrine when contained in a drug that is in liquid or gel form marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act (which shall be considered a listed chemical).

Amends CSA to revise the definition of: (1) "regulated transaction" to provide that the threshold for any distributor sale of products containing pseudoephedrine products in liquid or gel form, or containing phenylpropanolamine products, shall be nine grams of pseudoephedrine or phenylpropanolamine in a single transaction and sold in package sizes of not more than three grams of pseudoephedrine or phenylpropanolamine base; and (2) "ordinary over-the-counter pseudoephedrine or phenylpropanolamine product" to mean certain products containing pseudoephedrine in liquid or gel form (currently, products containing pseudoephedrine) that meet specified requirements.

What's happening now June 28, 2004

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1
D
Larsen, Rick
Washington · Jun 18, 2004
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4395: Ephedrine Alkaloids Regulation Act of 2004. 108th Congress. Open America. https://openamerica.io/bill/108-HR-4395/
MLA
"H.R. 4395: Ephedrine Alkaloids Regulation Act of 2004." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-4395/.
Bluebook (legal)
H.R. 4395, 108th Cong. (2026), https://openamerica.io/bill/108-HR-4395/.
Markdown link
[H.R. 4395: Ephedrine Alkaloids Regulation Act of 2004](https://openamerica.io/bill/108-HR-4395/)
Report a problem